{"schema_version":"1","generated_at":"2026-11-17T20:06:00.726Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/darren-mcguire","json_url":"https://www.findmykol.com/kol/darren-mcguire/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"darren-mcguire","name":"Darren McGuire","credential":"MD","title":"Distinguished Teaching Professor","specialty":"Cardiovascular Disease","specialty_raw":"Cardiovascular Disease","therapeutic_area":"Genitourinary","therapeutic_areas":["Genitourinary","Cardiology"],"institution":"University of Texas Southwestern Medical School","institution_url":"https://www.findmykol.com/institution/ut-southwestern-medical-center","city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1336106715","orcid":"0000-0002-6412-7989","openalex":"A5071945904"},"summary":"Darren McGuire is Distinguished Teaching Professor at University of Texas Southwestern Medical School. OpenAlex indexes 755 publications with 109,965 citations (h-index 117); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Cardiovascular Disease profiles in the FindMyKOL directory.","overview":{"text":"Darren McGuire, MD, is Distinguished Teaching Professor at University of Texas Southwestern Medical School. The public record shows 755 publications with 109,965 citations (h-index 117), centered on Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Heart Failure Treatment and Management. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 33 companies, 1 NIH-funded awards (2005–2007).","bullets":["Most recent indexed publication: 2026 · European heart journal. Cardiovascular pharmacotherapy","Top research focus: Diabetes Treatment and Management","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 33 companies"],"generated_at":"2026-11-17"},"focus":{"indications":[{"label":"Type 2 Diabetes","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":4},{"label":"Diabetes Mellitus","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"COPD","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Coronary Artery Disease / ACS","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Diabetic Complications","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"ESRD / Dialysis","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Gout","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Heart Failure","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Hypertension","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Stroke","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Substance Use Disorders","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1}],"research_topics":["Diabetes Treatment and Management","Diabetes, Cardiovascular Risks, and Lipoproteins","Heart Failure Treatment and Management","Diabetes Management and Research","Chronic Kidney Disease and Diabetes"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Jardiance","generic":"Empagliflozin","trials":0,"payments":29,"publications":1,"mentions":30},{"name":"Farxiga","generic":"Dapagliflozin","trials":0,"payments":13,"publications":11,"mentions":24},{"name":"Mounjaro","generic":"Tirzepatide","trials":0,"payments":11,"publications":3,"mentions":14}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Eli Lilly and Company","trials":0,"payments":76,"mentions":76},{"name":"Novo Nordisk AS","trials":0,"payments":34,"mentions":34},{"name":"Boehringer Ingelheim International GmbH","trials":0,"payments":32,"mentions":32}]}},"scholarship":{"works_count":755,"cited_by_count":109965,"h_index":117,"i10_index":397,"pubmed_count":66,"latest_activity_year":2026,"citation_standing":{"top_percent":1,"cohort":"Cardiovascular Disease","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT00424762","title":"Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride","phase":"PHASE4","status":"COMPLETED","role":"Investigator","sponsor":"University of Texas Southwestern Medical Center","source_url":"https://clinicaltrials.gov/study/NCT00424762","trial_url":"https://www.findmykol.com/trial/NCT00424762"}],"source":"trials"},"payments":{"company_count":33,"program_years":{"first":2021,"last":2025},"rows_total":64,"shown":3,"withheld":61,"rows":[{"payer":"Novo Nordisk AS","program_year":2025,"amount_usd":39120.37,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336106715"},{"payer":"Eli Lilly and Company","program_year":2025,"amount_usd":9750.24,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336106715"},{"payer":"Lexicon Pharmaceuticals, Inc.","program_year":2025,"amount_usd":7877,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336106715"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1336106715","source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cardiovascular","share_pct":100,"classes_total":4,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":34.4,"drugs":[{"name":"Carvedilol","share_pct":100}],"max_beneficiaries":null},{"class":"Statin","setting":"prescribed","share_pct":28.1,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2005,"last":2007},"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"M01RR000633","title":"ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE","fiscal_year":2007,"amount_usd":13052,"organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/M01RR000633"},{"project":"M01RR000633","title":"ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE","fiscal_year":2006,"amount_usd":108043,"organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/M01RR000633"},{"project":"M01RR000633","title":"ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE","fiscal_year":2005,"amount_usd":12032,"organization":"UNIVERSITY OF TEXAS SW MED CTR/DALLAS","source_url":"https://reporter.nih.gov/quickSearch/M01RR000633"}],"source":"grants"},"congress":{"count":84,"years":{"first":2018,"last":2026},"societies":["ADA","AHA","ASN","ENDO","ESC","IDSA"],"shown":3,"withheld":81,"rows":[{"title":"1696-P: Effect of Semaglutide on COVID-19–Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials","society":"ADA","meeting":"ADA Scientific Sessions","year":2026,"role":"co_author","presentation_type":"poster","contribution_type":"abstract","doi":"https://doi.org/10.2337/db26-1696-p","source_url":"https://doi.org/10.2337/db26-1696-p","status":"verified"},{"title":"Ertugliflozin Effects on Cardiovascular, Kidney, and Inflammatory Biomarkers in VERTIS CV: Exploratory Analyses","society":"ASN","meeting":"ASN Kidney Week","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1681/asn.2026p48azkdr","source_url":"https://doi.org/10.1681/asn.2026p48azkdr","status":"verified"},{"title":"145-OR: ADA Presidents' Select Abstract: Association of Age at Type 1 Diabetes Diagnosis with Fatal Cardiovascular and Kidney Events","society":"ADA","meeting":"ADA Scientific Sessions","year":2025,"role":"co_author","presentation_type":"oral","contribution_type":"abstract","doi":"https://doi.org/10.2337/db25-145-or","source_url":"https://doi.org/10.2337/db25-145-or","status":"verified"}],"source":"congress"},"publications":{"total":66,"shown":5,"withheld":61,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"PharmaPlain: SOUL trial looking at the effect of oral semaglutide on cardiovascular outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease.","year":2026,"journal":"European heart journal. Cardiovascular pharmacotherapy","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42647148/","status":"verified"},{"title":"Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis.","year":2026,"journal":"European journal of preventive cardiology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42875024/","status":"verified"},{"title":"Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.","year":2026,"journal":"Diabetes care","types":["Journal Article","Randomized Controlled Trial"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41940793/","status":"verified"},{"title":"SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.","year":2026,"journal":"Diabetes care","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42690158/","status":"verified"},{"title":"Response to Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257-265.","year":2026,"journal":"Diabetes care","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42160596/","status":"verified"}],"most_cited":{"total":755,"shown":5,"withheld":750,"rows":[{"title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association.","year":2015,"cited_by_count":8265,"type":"article","source_url":"https://doi.org/10.1161/cir.0000000000000152"},{"title":"Heart Disease and Stroke Statistics—2016 Update","year":2015,"cited_by_count":6597,"type":"article","source_url":"https://doi.org/10.1161/cir.0000000000000350"},{"title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","year":2018,"cited_by_count":6356,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1812389"},{"title":"Heart Disease and Stroke Statistics—2015 Update","year":2014,"cited_by_count":5796,"type":"article","source_url":"https://doi.org/10.1161/cir.0000000000000152"},{"title":"Heart Disease and Stroke Statistics—2014 Update","year":2013,"cited_by_count":5215,"type":"article","source_url":"https://doi.org/10.1161/01.cir.0000441139.02102.80"}]},"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"researchgate","url":"https://www.researchgate.net/profile/Darren-Mcguire","status":"verified"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://www.cardiometabolichealth.org/faculty/darren-mcguire/","platform":"other","status":"verified"},{"url":"https://x.com/sandeepdasmd","label":"Sandeep Das (@sandeepdasmd) on X congratulates Darren McGuire and colleagues on an updated SGLT2 inhibitor meta-analysis in JAMA Cardiology","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Master of Health Sciences, Duke University School of Medicine (2001)","source_url":"https://www.cardiometabolichealth.org/faculty/darren-mcguire/","status":"provisional","collected_at":"2026-11-13"},{"value":"MD, Johns Hopkins University School of Medicine","source_url":"https://profiles.utsouthwestern.edu/profile/19303/darren-mcguire.html","status":"verified","collected_at":"2026-11-13"}]},"awards":{"total":14,"shown":3,"rows":[{"value":"Regents Outstanding Teaching Award, UT System Board of Regents (2013)","source_url":"https://profiles.utsouthwestern.edu/profile/19303/darren-mcguire.html","status":"verified","collected_at":"2026-11-13"},{"value":"L. David Hillis Award for Excellence in Teaching (2012)","source_url":"https://profiles.utsouthwestern.edu/profile/19303/darren-mcguire.html","status":"verified","collected_at":"2026-11-13"},{"value":"Outstanding Research Mentor Award (2012)","source_url":"https://profiles.utsouthwestern.edu/profile/19303/darren-mcguire.html","status":"verified","collected_at":"2026-11-13"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Lead Physician, Parkland Health Outpatient Cardiology Clinic","source_url":"https://profiles.utsouthwestern.edu/profile/19303/darren-mcguire.html","status":"verified","collected_at":"2026-11-13"}]},"media":{"total":4,"shown":3,"rows":[{"value":"CardioNerds podcast: 363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire","source_url":"https://www.cardionerds.com/363-glp-1-agonists-diving-into-the-data-with-dr-darren-mcguire/","status":"provisional","collected_at":"2026-11-13"},{"value":"PeerView Heart, Lung & Blood CME/CNE/CPE audio podcast episode (Translating Data Into Practice, weight loss pharmacotherapy and cardiovascular outcomes)","source_url":"https://podcasts.apple.com/us/podcast/darren-mcguire-md-mhsc-translating-data-into-practice/id160881390?i=1000638339630&uo=4","status":"provisional","collected_at":"2026-11-13"},{"value":"Video: Dr. Darren McGuire, Inside the Studio w/ Dr. Stephanie Coulter","source_url":"https://www.youtube.com/watch?v=CUpPnxWmKk8","status":"provisional","collected_at":"2026-11-13"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Ad hoc consultant, FDA Cardiovascular and Renal Drugs Advisory Committee","source_url":"https://utswmed.org/doctors/darren-mcguire/","status":"verified","collected_at":"2026-11-13"}]}},"similar":[{"name":"Andrew Levey","slug":"andrew-levey","institution":"Tufts Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/andrew-levey","json_url":"https://www.findmykol.com/kol/andrew-levey/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Toni Choueiri","slug":"toni-choueiri","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/toni-choueiri","json_url":"https://www.findmykol.com/kol/toni-choueiri/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":61,"congress":81,"publications":61}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-13"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-13"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-13"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-13"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-13"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-13"}},"methodology_url":"https://www.findmykol.com/about#methodology"}